cellestia-biotech-employee

Dr. Josep Tabernero

Clinical Advisory Board Member

M.D., Ph.D., Professor of Oncology, Head of the Medical Oncology Department at the Vall d' Hebron University Hospital in Barcelona and Director of the Vall d' Hebron Institute of Oncology. He is very actively involved in translational research and pharmacodynamics phase 1 studies with molecular targeted therapies, with a special focus on EGFR family and various signalling pathway inhibitors. He co-authored approximately 350 peer-reviewed papers and is/has been on the Educational and Scientific Committees of the ESMO, ECCO, ASCO, AACR, AACR/NCI/EORTC, ASCO Gastrointestinal, and WCGIC meetings. He was elected President of the European Society for Medical Oncology (ESMO) for the 2018-2019 period with ESMO being the leading European cancer organization. Linkedin Profile